Syngene International Ltd's Q1FY26 Quarter Results
- 24 Jul 2025
Result Summary
- Syngene International Ltd reported a 4.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1FY26). On a year-on-year (YoY) basis, it witnessed a growth of 10.4%.
- Its expenses for the quarter were up by 9.2% QoQ and 7.1% YoY.
- The net profit decreased 54.0% QoQ and increased 14.5% YoY.
- The earnings per share (EPS) of Syngene International Ltd stood at 2.1 during Q1FY26.
Financial Statments for Q1FY26
| (₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 892.20 | 933.00 | 807.80 | -4.4% | 10.4% |
Total Expenses | 790.90 | 724.00 | 738.50 | 9.2% | 7.1% |
Profit Before Tax | 101.30 | 209.00 | 101.30 | -51.5% | 0.0% |
Tax | 14.60 | 20.40 | 25.60 | -28.4% | -43.0% |
Profit After Tax | 86.70 | 188.60 | 75.70 | -54.0% | 14.5% |
Earnings Per Share | 2.10 | 4.70 | 1.90 | -55.3% | 10.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Syngene International Ltd is a leading contract research and manufacturing services company, positioned within the biotechnology and pharmaceutical industry. It primarily provides integrated drug discovery and development services to pharmaceutical, biotechnology, and agrochemical companies globally. The services offered by Syngene include discovery chemistry and biology, safety assessment, pharmaceutical development, and manufacturing capabilities. The company is known for its collaborative approach in helping clients accelerate the drug development process. As of the latest information available, Syngene has been focusing on expanding its infrastructure and capabilities to better serve its clients and to cater to the growing demand for outsourced research and manufacturing services.
Revenue
In the first quarter of the fiscal year 2026 (Q1FY26), Syngene International Ltd reported a total income of ₹892.20 crores. This represents a decrease of 4.4% compared to the previous quarter (Q4FY25), where the total income stood at ₹933.00 crores. However, on a year-over-year basis, there was a notable increase of 10.4% from ₹807.80 crores in Q1FY25. This upward trend in annual revenue indicates a growth trajectory in the company's income generation over the past year. The quarter-over-quarter decline may reflect fluctuations in demand or project timelines, which are common in the contract services industry.
Profitability
The company's profitability indicators reveal significant changes compared to both the previous quarter and the same quarter last year. Profit Before Tax (PBT) for Q1FY26 was ₹101.30 crores, which is a reduction of 51.5% from ₹209.00 crores in Q4FY25. Year-over-year, the PBT remained constant at ₹101.30 crores, showing no change from Q1FY25. Despite the stability in year-on-year terms, the quarter-on-quarter decline is substantial. Profit After Tax (PAT) for Q1FY26 was ₹86.70 crores, down by 54.0% from ₹188.60 crores in Q4FY25, but up by 14.5% from ₹75.70 crores in Q1FY25. The tax expense in Q1FY26 was ₹14.60 crores, a decrease of 28.4% from the previous quarter and 43.0% from the same quarter last year.
Operating Metrics
In terms of operational performance, key metrics such as total expenses saw an increase in Q1FY26, amounting to ₹790.90 crores. This marks a 9.2% rise from Q4FY25's expenses of ₹724.00 crores and a 7.1% increase from ₹738.50 crores in Q1FY25. This increase in expenses suggests a possibly higher level of operational activity or investment in resources. The Earnings Per Share (EPS) in Q1FY26 was ₹2.10, which is a drop of 55.3% from ₹4.70 in Q4FY25, but a rise of 10.5% compared to ₹1.90 in Q1FY25. These metrics reflect the company's operational dynamics and financial health over the given periods.